A range of presentations in humans was seen that included ocular infections in 76.9% (9 cases of keratitis, 1 of endophthalmitis ... and that additional research elucidates the pathogenesis of fungal ...

When managing an irritated cornea, choosing among fortified antibiotics, oral antivirals, anti-inflammatories or combination ...

To compare safety, efficacy and cost–effectiveness of voriconazole with natamycin, a double-blinded RCT was conducted in two hospitals in India in 2010. The design was superior to antecedent ...

One notable study compared PACK-CXL with standard antimicrobial therapy in a randomized trial involving patients with bacterial, fungal, or mixed infectious keratitis. The results indicated that ...

One lost to follow-up. † Four grew bacteria; two responded to antifungal medication. Sensitivity: (15 + 2)/(16 + 2) = 0.944 (94%). False positive: 4/(29 - 18) = 0. ...

The global fungal keratitis treatment market is on a robust growth trajectory, with projections indicating a rise from USD 571.7 million in 2023 to an impressive USD 1.0 billion by 2033. This ...

Fungal infections, such as athlete’s foot and ringworm, occur when one type of fungal microbe becomes too prevalent in one area of the body so that the immune system cannot defeat it. Like many ...

Human fungal pathogens exemplify a severe threat to health due to their complex infection strategies and the host's immune system's failure to eradicate ...

However, fungal infections are contagious, and psoriasis is not. The causes and treatment are also different. The autoimmune activity in psoriasis causes the rapid overgrowth of skin cells.

Purpose: This study aimed to report the use, efficacy, and safety of intracameral voriconazole as an adjuvant treatment for deep fungal keratitis. Methods: This was a prospective case series of seven ...